Abstract
PurposeSupported by the UK's eight principle funders of biomedical and health research, UK PubMed Central (UKPMC) is being developed in close consultation with its intended user community – the researchers. This paper seeks to outline why there is a need to develop a UK‐specific version of this well‐known and very popular free service, and what practical approaches have taken towards bringing a Beta service live for all to use and feedback on.Design/methodology/approachThe approach to development of UKPMC has been consultative and iterative. Through surveys, focus groups and one‐to‐one user tests the aim has been to develop a service which can fit neatly into a researcher's workflow. Coordinating the programme itself has required close collaboration between organisations which are quite diverse both culturally and administratively.FindingsThrough developing UKPMC, technology has been melded together with practical delivery. The text mining functionality that the service now offers is truly innovative, and there is further potential to develop this. The recently launched Beta service (beta.ukpmc.ac.uk) will continue to be honed – particularly its text mining functionality – through ongoing user consultation and feedback. It is perceived that this flexible approach to development is essential in offering a service that is truly useful for the UK's life sciences research community and offers a compelling reason to use it as a valid and ground breaking alternative to PubMed Central (the US version).Originality/valueThe originality and value of UKPMC should be judged by the research community. All life sciences researchers are invited to try the beta site.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
